This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revision | |||
home:symptoms:gastrointestinal [03.13.2019] – [Bleeding from bowel] sallieq | home:symptoms:gastrointestinal [09.14.2022] (current) – external edit 127.0.0.1 | ||
---|---|---|---|
Line 62: | Line 62: | ||
==== Further researxh ==== | ==== Further researxh ==== | ||
- | Findings suggest that neither olmesartan nor other ARBs were associated with diarrhea among patients undergoing endoscopy. The spruelike enteropathy recently associated with olmesartan is likely a rare adverse effect and milder presentations are unlikely. | + | Findings suggest that neither olmesartan nor other ARBs were associated with diarrhea among patients undergoing endoscopy. The spruelike enteropathy recently associated with olmesartan is likely a rare adverse effect and milder presentations are unlikely. |
- | In a methotrexate-induced model of intestinal mucositis, olmesartan reduced inflammation and induced enteropathy characterized by severe diarrhea, weight loss, and reduced sucrose activity. | + | In a methotrexate-induced model of intestinal mucositis, olmesartan reduced inflammation and induced enteropathy characterized by severe diarrhea, weight loss, and reduced sucrose activity. |
+ | < | ||
===== Notes and comments ===== | ===== Notes and comments ===== | ||
- | ===== References ===== | + | ===== References =====</ |